Global Health Limited
Global Health Limited (MEDANTA.BO) Stock Overview
Explore Global Health Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
312B
P/E Ratio
60.33
EPS (TTM)
$19.12
ROE
0.15%
MEDANTA.BO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Global Health Limited (MEDANTA.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 53.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1576.45.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 60.33 and a market capitalization of 312B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.